Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | TTPA | P49638 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | GSTP1 | P09211 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.85 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.78 |
| ▸ | PDE4A | P27815 | 1/20 | 0.70 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.70 |
| ▸ | GSTO1 | P78417 | 2/20 | 0.69 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.67 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.64 |
| ▸ | AKT1 | P31749 | 4/20 | 0.58 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.58 |
| ▸ | PHLPP1 | O60346 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alpha-Tocopherol SCHEMBL14297170 | 1.00 | LMNA (1.00) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL14167439 | 1.00 | LMNA (1.00) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL13055549 | 1.00 | LMNA (1.00) | LMNATTPAMAPTMEN1KMT2A | |
| SCHEMBL3109160 | 1.00 | LMNA (1.00) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL10295722 | 1.00 | LMNA (1.00) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL8408151 | 1.00 | LMNA (1.00) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tochopherol SCHEMBL22303 | 1.00 | LMNA (1.00) | LMNATTPAMAPTMEN1KMT2A | |
| SCHEMBL15441194 | 1.00 | LMNA (1.00) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tocopherol SCHEMBL20817063 | 1.00 | LMNA (1.00) | LMNATTPAMAPTMEN1KMT2A | |
| Alpha-Tochopherol SCHEMBL14315133 | 1.00 | LMNA (1.00) | LMNATTPAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023017533-A1 | A NUTRITIONAL CAPSULE OF AYURVEDIC HERBS, UNANI HERBS, MINERALS, AMINO ACIDS, VITAMINS, PROBIOTIC AND NUTRACEUTICALS | AUFFULLEN HEALTHCARE PVT. LTD. (IN) | 2023-02-16 | — | — | WO | disclosed |
| US-20220169834-A1 | Method for Improving UV Weatherability of Thermoplastic Vulcanizates | CELANESE INTERNATIONAL CORPORATION | 2022-06-02 | — | — | US | disclosed |
| US-11246853-B2 | Method for evaluating the ability of a composition to prevent muscle damage and fatigue; food supplement and drug | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2022-02-15 | — | — | US | disclosed |
| US-20210338633-A1 | METHOD FOR EVALUATING THE ABILITY OF A COMPOSITION TO PREVENT MUSCLE DAMAGE AND FATIGUE; FOOD SUPPLEMENT AND DRUG | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2021-11-04 | — | — | US | disclosed |
| EP-3449252-B1 | METHOD FOR EVALUATING THE ABILITY OF A COMPOSITION TO PREVENT MUSCLE DAMAGE AND FATIGUE | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2020-05-06 | — | — | EP | disclosed |
| US-20190160042-A1 | METHOD FOR EVALUATING THE ABILITY OF A COMPOSITION TO PREVENT MUSCLE DAMAGE AND FATIGUE; FOOD SUPPLEMENT AND DRUG | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2019-05-30 | — | — | US | disclosed |
| EP-3027170-B1 | NOVEL USES OF ALKYLPOLYGLYCOSIDES FOR SOLUBILISING VITAMIN E IN WATER, CORRESPONDING COMPOSITIONS | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2018-04-25 | — | — | EP | disclosed |
| WO-2017187033-A1 | METHOD FOR EVALUATING THE ABILITY OF A COMPOSITION TO PREVENT MUSCLE DAMAGE AND FATIGUE; FOOD SUPPLEMENT AND DRUG | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2017-11-02 | — | — | WO | disclosed |
| US-20160193340-A1 | NOVEL USES OF ALKYL POLYGLYCOSIDES FOR SOLUBILISING VITAMIN E IN WATER; COMPOSITIONS COMPRISING SAME | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2016-07-07 | — | — | US | disclosed |
| EP-3027170-A1 | NOVEL USES OF ALKYL POLYGLYCOSIDES FOR SOLUBILISING VITAMIN E IN WATER; COMPOSITIONS COMPRISING SAME | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2016-06-08 | — | — | EP | disclosed |
| WO-2015015092-A1 | NOVEL USES OF ALKYL POLYGLYCOSIDES FOR SOLUBILISING VITAMIN E IN WATER; COMPOSITIONS COMPRISING SAME | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2015-02-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190160042-A1 | METHOD FOR EVALUATING THE ABILITY OF A COMPOSITION TO PREVENT MUSCLE DAMAGE AND FATIGUE; FOOD SUPPLEMENT AND DRUG | GYS1, PYGM, MYOF | LMNA 1680/4885TTPA 14/4885MAPT 4019/4885 |
| US-11246853-B2 | Method for evaluating the ability of a composition to prevent muscle damage and fatigue; food supplement and drug | GYS1, PYGM, MYOF | LMNA 1680/4885TTPA 14/4885MAPT 4019/4885 |
| US-20210338633-A1 | METHOD FOR EVALUATING THE ABILITY OF A COMPOSITION TO PREVENT MUSCLE DAMAGE AND FATIGUE; FOOD SUPPLEMENT AND DRUG | PYGM, TNNC1, GYS1 | LMNA 369/4885TTPA 89/4885MAPT 4593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.